Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?
暂无分享，去创建一个
M. Nardi | W. Wiersinga | G. Veronesi | L. Bartalena | M. Soeters | P. Perros | M. Stahl | C. Azzolini | C. Bournaud | G. Arx | M. Bernard | C. Daumerie | M. Mourits | M. Marinò | A. Boschi | M. Salvi | L. Sassi | N. Currò | K. Boboridis | C. Marcocci | G. Krassas | L. Baldeschi | G. Kahaly | on behalf of the European Group on Graves’ Orbitopathy